T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant ; volume:47 ; number:1 ; day:9 ; month:8 ; year:2024 ; pages:1-7 ; date:12.2024
Neurosurgical review ; 47, Heft 1 (9.8.2024), 1-7, 12.2024
- Urheber
-
Onishi, Shumpei
Kojima, Masato
Yamasaki, Fumiyuki
Amatya, Vishwa Jeet
Yonezawa, Ushio
Taguchi, Akira
Ozono, Iori
Go, Yukari
Takeshima, Yukio
Hiyama, Eiso
Horie, Nobutaka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10143-024-02632-5
- URN
-
urn:nbn:de:101:1-2410291004528.723037185172
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Onishi, Shumpei
- Kojima, Masato
- Yamasaki, Fumiyuki
- Amatya, Vishwa Jeet
- Yonezawa, Ushio
- Taguchi, Akira
- Ozono, Iori
- Go, Yukari
- Takeshima, Yukio
- Hiyama, Eiso
- Horie, Nobutaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Sarcomatous transformation of IDH-mutant astrocytoma matching to methylation class oligosarcoma following embolization, a case report